Intensive management of diabetes is identified as a critical component of inpatient care. However, the fundamental question that remains is whether controlling glycemia in noncritically ill diabetes patients at the lower end of the current guidelines improves outcomes of hospitalization, long-term outcomes of the primary condition, and long-term outcomes of diabetes compared with average glycemia greater than 180 mg/dl. A group of clinical investigators—Planning Research in Inpatient Diabetes (PRIDE)—is preparing randomized controlled trials with the hope of defining optimal glycemic targets for hospitalized patients with diabetes. Given the variety of clinical situations that can occur in the inpatient setting, many medical centers have established dedicated inpatient diabetes teams. There is ample evidence, albeit retrospective, that these teams improve inpatient glucose control and reduce lengths of hospital stays. Using hospitalization as an opportunity to educate patients about diabetes and to optimize their treatment regimen may improve long-term outpatient glycemic control.
Diabetes Control and Complications Trial Research Group. The effect of intensive therapy of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med.1993;329 (14): 977–86.
2.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet.1998;352 (9131): 837–53.
3.
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med.2001;345 (19): 1359–67.
4.
Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med.2008;358 (24): 2545–59.
5.
ADVANCE Collaborative Group, PatelAMacMahonSChalmersJNealBBillotLWoodwardMMarreMCooperMGlasziouPGrobbeeDHametPHarrapSHellerSLiuLManciaGMogensenCEPanCPoulterNRodgersAWilliamsBBompointSde GalanBEJoshiRTravertF. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med.2008;358 (24): 2560–72.
6.
DuckworthWAbrairaCMoritzTRedaDEmanueleNReavenPDZieveFJMarksJDavisSNHaywardRWarrenSRGoldmanSMcCarrenMVitekMEHendersonWGHuangGD, VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med.2009;360 (2): 129–39.
7.
BrunkhorstFMEngelCBloosFMeier-HellmannARagallerMWeilerNMoererOGruendlingMOppertMGrondSOlthoffDJaschinskiUJohnSRossaintRWelteTSchaeferMKernPKuhntEKiehntopfMHartogCNatansonCLoefflerMReinhartK, German Competence Network Sepsis (SepNet)Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med.2008;358 (2): 125–39.
8.
PreiserJCDevosPRuiz-SantanaSMélotCAnnaneDGroeneveldJIapichinoGLeverveXNitenbergGSingerPWernermanJJoannidisMStecherAChioléroR. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: The Glucontrol study. Intens Care Med.2009;35 (10): 1738–48.
9.
NICE-SUGAR Study InvestigatorsFinferSChittockDRSuSYBlairDFosterDDhingraVBellomoRCookDDodekPHendersonWRHébertPCHeritierSHeylandDKMcArthurCMcDonaldEMitchellIMyburghJANortonRPotterJRobinsonBGRoncoJJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med.2009;360 (13): 1283–97.
10.
Centers for Disease Control and Prevention. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA. Available from http://www.cdc.gov. Accessed April 11, 2011.
11.
American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care.2008;31 (3): 596–615.
12.
LevetanCSPassaroMJablonskiKKassMRatnerRE. Unrecognized diabetes among hospitalized patients. Diabetes Care.1998;21 (2): 246–9.
13.
WexlerDJNathanDMGrantRWReganSVan LeuvanALCaglieroE. Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of diabetes. J Clin Endocr Metab.2008;93 (11): 4238–44.
14.
CapesSEHuntDMalmbergKPathakPGersteinHC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke.2001;32 (10): 2426–32.
15.
CapesSEHuntDMalmbergKGersteinHC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet.2000;355 (9206): 773–8.
16.
BolkJvan der PloegTCornelJHArnoldAESepersJUmansVA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol.2001;79 (2–3): 207–14.
17.
SuleimanMHammermanHBoulosMKapeliovichMRSuleimanAAgmonYMarkiewiczWAronsonD. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: A prospective study. Circulation.2005;111 (6): 754–60.
18.
RamosMKhalpeyZLipsitzSSteinbergJPanizalesMTZinnerMRogersSO. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg.2008;248 (4): 585–91.
19.
ThomasMCMoranJMathewTHRussGRRaoMM. Early perioperative hyperglycaemia and renal allograft rejection in patients without diabetes. BMC Nephrol.2000;1: 1. Available from http://biomed-central.com/1471-2369/1/1.
20.
McAlisterFAMajumdarSRBlitzSRoweBHRomneyJMarrieTJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care.2005;28 (4): 810–5.
21.
LinLYLinHCLeePCMaWYLinHD. Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci.2007;333 (5): 261–5.
22.
UmpierrezGEIsaacsSDBazarganNYouXThalerLMKitabchiAE. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab.2002;87 (3): 978–82.
23.
UmpierrezGESmileyDJacobsSPengLTemponiAMulliganPUmpierrezDNewtonCOlsonDRizzoM. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care.2011;34 (2): 256–61.
SheetzMJKingGL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA.2002;288 (20): 2579–88.
26.
EspositoKNappoFMarfellaRGiuglianoGGiuglianoFCiotolaMQuagliaroLCerielloAGiuglianoD. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation.2002;106 (16): 2067–72.
27.
JoshiNCaputoGMWeitekampMRKarchmerAW. Infections in patients with diabetes mellitus. N Engl J Med.1999;341 (25): 1906–12.
28.
MarfellaRQuagliaroLNappoFCerielloAGiuglianoD. Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest.2001;108 (4): 635–6.
29.
Calles-EscandonJCipollaM. Diabetes and endothelial dysfunction: A clinical perspective. Endocr Rev.2001;22 (1): 36–52.
30.
GreselePGuglielminiGDe AngelisMCiferriSCiofettaMFalcinelliELalliCCiabattoniGDavìGBolliGB. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol.2003;41 (6): 1013–20.
31.
SchuetzPCastroPShapiroNI. Diabetes and sepsis: Preclinical findings and clinical relevance. Diabetes Care.2011;34 (3): 771–8.
32.
FinneySJZekveldCEliaAEvansTW. Glucose control and mortality in critically ill patients. JAMA.2003;290 (15): 2041–7.
33.
MoghissiESKorytkowskiMTDiNardoMEinhornDHellmanRHirschIBInzucchiSEIsmail-BeigiFKirkmanMSUmpierrezGE. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care.2009;32 (6): 1119–31.
34.
KansagaraDFuRFreemanMWolfFHelfandM. Intensive insulin therapy in hospitalized patients: A systematic review. Ann Intern Med.2011;154 (4): 268–82.
35.
FalcigliaMFreybergRWAlmenoffPLD'AlessioDARenderML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med.2009;37 (12): 3001–9.
36.
DavisTMBrownSGJacobsIGBulsaraMBruceDGDavisWA. Determinants of severe hypoglycemia complicating type 2 diabetes: The Fremantle diabetes study. J Clin Endocrinol Metab.2010;95 (5): 2240–7.
37.
KaganskyNLevySRimonECojocaruLFridmanAOzerZKnoblerH. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med.2003;163 (15): 1825–9.
38.
GearhartJGDuncanJL3rdReplogleWHForbesRCWalleyEJ. Efficacy of sliding-scale insulin therapy: A comparison with prospective regimens. Fam Pract Res J.1994;14 (4): 313–22.
39.
QuealeWSSeidlerAJBrancatiFL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med.1997;157 (5): 545–52.
40.
UmpierrezGESmileyDZismanAPrietoLMPalacioACeronMPuigAMejiaR. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care.2007;30 (9): 2181–6.
41.
HirschIB. Sliding scale insulin—time to stop sliding. JAMA.2009;301 (2): 213–4.
42.
KlonoffDC. Hospital diabetes: Why quality of care matters to both patients and hospitals. J Diab Sci Technol.2011;5 (1): 1–4.
SeggelkeSAGibbsJDrazninB. Pilot study of using Neutral Protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes. J Hosp Med.2011;6 (3): 175–6.
45.
KimmelBSullivanMMRushakoffRJ. Survey on transition from inpatient to outpatient for patients on insulin: What really goes on at home?Endocr Pract.2010;16 (5): 785–91.
46.
LevetanCSSalasJRWiletsIFZumoffB. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med.1995;99 (1): 22–8.
47.
LevetanCSPassaroMDJablonskiKARatnerRE. Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care.1999;22 (11): 1790–5.
48.
BraithwaiteSMageeMSharrettsJMSchnipperJLAminAMaynardG. The case of supporting inpatient glycemic control programs now: The evidence and beyond. J Hosp Med.2008;3 (5 Suppl): 6–16.
49.
KoproskiJPrettoZPoretskyL. Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care.1997;20 (10): 1553–5.
50.
RomanSHChassinMR. Windows of opportunity to improve diabetes care when patients with diabetes are hospitalized for other conditions. Diabetes Care.2001;24 (8): 1371–6.
